Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Gene Technology, ExonHit Therapeutics, Agilent Technologies

Oxford Gene Technology has added four prokaryote species its Chip² family of chromatin immunoprecipitation (ChIP)-on-chip microarray products, the company said this week.
Chip² arrays are now available for Escherichia coli 0157, Salmonella typhimurium LT2, Salmonella typhimurium SL1344, and Streptomyces coelicolor.
In May, OGT launched its first product in the Chip² portfolio, an E. coli K12 ChIP-on-chip microarray (see BAN 5/30/2006).

ExonHit Therapeutics this week launched its SpliceArray internet portal. The firm claims the online tool will enable the biomedical community to order microarrays designed to study the expression of the entire human genome.
According to ExonHit, customers will now be able to order arrays from ExonHit's new catalogue, which now offers 75 microarrays. In addition, users can access ExonHit’s genome expression map, the company said.
Finally, scientists will be able to submit their list of favorite genes in order to view the associated splicing events, and create customized microarrays. The microarrays can then be manufactured on different platforms based on agreements between ExonHit and Agilent or Affymetrix, the company said.
The SpliceArray portal can be accessed at

Agilent Technologies this week launched eArray 4.5, the latest installment of its online web tool. According to Agilent, eArray 4.5 now offers probe design capability. Agilent eArray v4.5 users can also query databases containing more than 21 million tiled comparative genomic hybridization and chromatin immunoprecipitation (ChIP)-on-chip probes, enabling them to create high-resolution arrays that target genomic regions of interest.
eArray 4.5 also contains genome-wide mouse and human ChIP probe databases, each containing 13 million probes, and mouse and human probe data sets of 8 million probes each for CGH applications. Agilent also recently added arrays for rhesus macaque, bovine, and canine species.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.